| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | beta-catenin binding | 9.33e-06 | 120 | 81 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 3.47e-05 | 16 | 81 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.52e-04 | 599 | 81 | 10 | GO:0050839 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 3.71e-08 | 10 | 77 | 4 | GO:0097105 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 5.81e-08 | 11 | 77 | 4 | GO:0097104 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.25e-07 | 13 | 77 | 4 | GO:0097090 | |
| GeneOntologyBiologicalProcess | membrane assembly | 1.40e-07 | 64 | 77 | 6 | GO:0071709 | |
| GeneOntologyBiologicalProcess | membrane biogenesis | 3.10e-07 | 73 | 77 | 6 | GO:0044091 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 1.18e-06 | 50 | 77 | 5 | GO:0044331 | |
| GeneOntologyBiologicalProcess | cell junction assembly | IL1RAPL1 CACNA1A NLGN3 SRPX2 NLGN4X NLGN4Y EPB41L5 CDH2 CDH4 CDH6 CDH7 CDH9 | 1.24e-06 | 569 | 77 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.59e-06 | 53 | 77 | 5 | GO:0016339 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 1.80e-06 | 24 | 77 | 4 | GO:0071625 | |
| GeneOntologyBiologicalProcess | adherens junction organization | 3.21e-06 | 61 | 77 | 5 | GO:0034332 | |
| GeneOntologyBiologicalProcess | synapse assembly | 1.94e-05 | 308 | 77 | 8 | GO:0007416 | |
| GeneOntologyBiologicalProcess | negative regulation of excitatory postsynaptic potential | 2.20e-05 | 15 | 77 | 3 | GO:0090394 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 2.71e-05 | 16 | 77 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | IL1RAPL1 NLGN3 ARID1B SRPX2 NLGN4X NLGN4Y EPB41L5 ARID1A CDH2 CDH4 TENM2 CDH6 CDH7 CDH9 | 3.96e-05 | 1077 | 77 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 4.12e-05 | 3 | 77 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 5.69e-05 | 56 | 77 | 4 | GO:0001941 | |
| GeneOntologyBiologicalProcess | cell junction organization | IL1RAPL1 CACNA1A NLGN3 SRPX2 NLGN4X NLGN4Y EPB41L5 FGFR2 CDH2 CDH4 CDH6 CDH7 CDH9 | 5.93e-05 | 974 | 77 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | presynapse assembly | 7.47e-05 | 60 | 77 | 4 | GO:0099054 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 8.21e-05 | 4 | 77 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 9.05e-05 | 63 | 77 | 4 | GO:0007157 | |
| GeneOntologyBiologicalProcess | presynapse organization | 1.61e-04 | 73 | 77 | 4 | GO:0099172 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.68e-04 | 313 | 77 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 1.96e-04 | 321 | 77 | 7 | GO:0099003 | |
| GeneOntologyBiologicalProcess | rhythmic synaptic transmission | 2.04e-04 | 6 | 77 | 2 | GO:0060024 | |
| GeneOntologyBiologicalProcess | synapse organization | IL1RAPL1 CACNA1A NLGN3 SRPX2 NLGN4X NLGN4Y FGFR2 CDH2 CDH6 CDH9 | 2.25e-04 | 685 | 77 | 10 | GO:0050808 |
| GeneOntologyBiologicalProcess | courtship behavior | 2.85e-04 | 7 | 77 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 3.17e-04 | 246 | 77 | 6 | GO:0045216 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 3.31e-04 | 248 | 77 | 6 | GO:0007623 | |
| GeneOntologyBiologicalProcess | brainstem development | 3.80e-04 | 8 | 77 | 2 | GO:0003360 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 3.80e-04 | 8 | 77 | 2 | GO:2000809 | |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 4.05e-04 | 167 | 77 | 5 | GO:0007043 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 4.08e-04 | 93 | 77 | 4 | GO:0099068 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 5.17e-04 | 42 | 77 | 3 | GO:0099560 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 6.77e-04 | 187 | 77 | 5 | GO:0007156 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | IL1RAPL1 CACNA1A NLGN3 ARID1B NLGN4X NLGN4Y SYNE1 GRIA4 CDH2 TENM2 FABP5 | 7.00e-04 | 939 | 77 | 11 | GO:0099537 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by trans-synaptic complex | 7.40e-04 | 11 | 77 | 2 | GO:0099545 | |
| GeneOntologyBiologicalProcess | regulation of oligodendrocyte progenitor proliferation | 8.86e-04 | 12 | 77 | 2 | GO:0070445 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 8.86e-04 | 12 | 77 | 2 | GO:2000807 | |
| GeneOntologyBiologicalProcess | neuron-neuron synaptic transmission | 8.86e-04 | 12 | 77 | 2 | GO:0007270 | |
| GeneOntologyCellularComponent | catenin complex | 1.52e-07 | 32 | 82 | 5 | GO:0016342 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 2.32e-07 | 4 | 82 | 3 | GO:0098983 | |
| GeneOntologyCellularComponent | postsynaptic membrane | IL1RAPL1 CACNA1A NLGN3 NLGN4X NLGN4Y SYNE1 GRIA4 CDH2 TENM2 CDH9 | 4.12e-06 | 405 | 82 | 10 | GO:0045211 |
| GeneOntologyCellularComponent | symmetric synapse | 1.62e-05 | 13 | 82 | 3 | GO:0032280 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.65e-05 | 137 | 82 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | synaptic membrane | IL1RAPL1 CACNA1A NLGN3 SRPX2 NLGN4X NLGN4Y SYNE1 GRIA4 CDH2 TENM2 CDH9 | 1.68e-05 | 583 | 82 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | extrinsic component of membrane | 3.36e-05 | 230 | 82 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | excitatory synapse | 6.38e-05 | 107 | 82 | 5 | GO:0060076 | |
| GeneOntologyCellularComponent | glutamatergic synapse | IL1RAPL1 CACNA1A NLGN3 SIRT2 NLGN4X NLGN4Y GRIA4 CDH2 TENM2 CDH6 CDH9 FABP5 | 7.85e-05 | 817 | 82 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 1.11e-04 | 24 | 82 | 3 | GO:0098985 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.40e-04 | 201 | 82 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | adherens junction | 1.87e-04 | 212 | 82 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | inhibitory synapse | 2.42e-04 | 31 | 82 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | cell-cell junction | 5.08e-04 | 591 | 82 | 9 | GO:0005911 | |
| GeneOntologyCellularComponent | bBAF complex | 6.70e-04 | 10 | 82 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.02e-03 | 523 | 82 | 8 | GO:0098984 | |
| GeneOntologyCellularComponent | npBAF complex | 1.34e-03 | 14 | 82 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 1.34e-03 | 14 | 82 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 1.76e-03 | 16 | 82 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | dendrite | IL1RAPL1 CACNA1A NLGN3 NLGN4X NLGN4Y SYNE1 GRIA4 MMP3 TENM2 CDH9 | 1.90e-03 | 858 | 82 | 10 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | IL1RAPL1 CACNA1A NLGN3 NLGN4X NLGN4Y SYNE1 GRIA4 MMP3 TENM2 CDH9 | 1.93e-03 | 860 | 82 | 10 | GO:0097447 |
| GeneOntologyCellularComponent | membrane protein complex | AKAP6 PIK3R4 CACNA1A NDUFB11 SYNE1 BEST3 GRIA4 CACNA1I CDH2 CDH4 CDH6 CDH7 CDH9 SNTB1 | 1.95e-03 | 1498 | 82 | 14 | GO:0098796 |
| GeneOntologyCellularComponent | postsynapse | IL1RAPL1 CACNA1A NLGN3 NLGN4X NLGN4Y SYNE1 GRIA4 CDH2 TENM2 CDH9 FABP5 | 2.04e-03 | 1018 | 82 | 11 | GO:0098794 |
| GeneOntologyCellularComponent | asymmetric synapse | 2.69e-03 | 477 | 82 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | glycinergic synapse | 2.76e-03 | 20 | 82 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | somatodendritic compartment | IL1RAPL1 CACNA1A NLGN3 SIRT2 NLGN4X NLGN4Y SYNE1 GRIA4 FEV MMP3 TENM2 CDH9 | 2.93e-03 | 1228 | 82 | 12 | GO:0036477 |
| GeneOntologyCellularComponent | calcium channel complex | 2.97e-03 | 73 | 82 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | preribosome, large subunit precursor | 3.04e-03 | 21 | 82 | 2 | GO:0030687 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.40e-03 | 157 | 82 | 4 | GO:0098839 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.58e-03 | 78 | 82 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 3.59e-03 | 785 | 82 | 9 | GO:0098797 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 3.60e-03 | 503 | 82 | 7 | GO:0099572 | |
| GeneOntologyCellularComponent | anchoring junction | 4.78e-03 | 976 | 82 | 10 | GO:0070161 | |
| GeneOntologyCellularComponent | sodium channel complex | 5.76e-03 | 29 | 82 | 2 | GO:0034706 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 6.16e-03 | 30 | 82 | 2 | GO:0016514 | |
| HumanPheno | Lack of peer relationships | 1.23e-05 | 10 | 25 | 3 | HP:0002332 | |
| HumanPheno | Abnormal peer relationships | 1.23e-05 | 10 | 25 | 3 | HP:5200016 | |
| HumanPheno | Abnormal relationship | 5.61e-05 | 16 | 25 | 3 | HP:5200024 | |
| HumanPheno | Personality disorder | 8.12e-05 | 18 | 25 | 3 | HP:0012075 | |
| HumanPheno | Abnormal social development | IL1RAPL1 CACNA1A NDUFB11 NLGN3 ARID1B DNAJC13 SRPX2 NLGN4X CYP27A1 SPRED1 CHD2 ARID1A CDH2 | 1.05e-04 | 908 | 25 | 13 | HP:0025732 |
| HumanPheno | Lack of spontaneous play | 1.38e-04 | 4 | 25 | 2 | HP:0000721 | |
| HumanPheno | Abnormal play | 1.38e-04 | 4 | 25 | 2 | HP:5200104 | |
| HumanPheno | Disinhibition | IL1RAPL1 CACNA1A NLGN3 ARID1B DNAJC13 SRPX2 NLGN4X CYP27A1 SPRED1 CHD2 ARID1A CDH2 | 1.62e-04 | 807 | 25 | 12 | HP:0000734 |
| HumanPheno | Inappropriate behavior | IL1RAPL1 CACNA1A NLGN3 ARID1B DNAJC13 SRPX2 NLGN4X CYP27A1 SPRED1 CHD2 ARID1A CDH2 | 1.62e-04 | 807 | 25 | 12 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | IL1RAPL1 CACNA1A NLGN3 ARID1B DNAJC13 SRPX2 NLGN4X CYP27A1 SPRED1 CHD2 ARID1A CDH2 | 1.62e-04 | 807 | 25 | 12 | HP:5200123 |
| HumanPheno | Social disinhibition | IL1RAPL1 CACNA1A NLGN3 ARID1B DNAJC13 SRPX2 NLGN4X CYP27A1 SPRED1 CHD2 ARID1A CDH2 | 1.62e-04 | 807 | 25 | 12 | HP:5200029 |
| Domain | Cadherin_cytoplasmic-dom | 6.31e-08 | 25 | 80 | 5 | IPR000233 | |
| Domain | Cadherin_C | 6.31e-08 | 25 | 80 | 5 | PF01049 | |
| Domain | Catenin_binding_dom | 1.39e-07 | 29 | 80 | 5 | IPR027397 | |
| Domain | - | 1.39e-07 | 29 | 80 | 5 | 4.10.900.10 | |
| Domain | Nlgn | 7.52e-07 | 5 | 80 | 3 | IPR000460 | |
| Domain | BAF250_C | 1.81e-05 | 2 | 80 | 2 | IPR033388 | |
| Domain | NLGN4 | 1.81e-05 | 2 | 80 | 2 | IPR030025 | |
| Domain | BAF250_C | 1.81e-05 | 2 | 80 | 2 | PF12031 | |
| Domain | BAF250/Osa | 1.81e-05 | 2 | 80 | 2 | IPR021906 | |
| Domain | Carboxylesterase_B_CS | 2.10e-05 | 13 | 80 | 3 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 2.66e-05 | 14 | 80 | 3 | PS00941 | |
| Domain | COesterase | 2.66e-05 | 14 | 80 | 3 | PF00135 | |
| Domain | CarbesteraseB | 2.66e-05 | 14 | 80 | 3 | IPR002018 | |
| Domain | - | 4.64e-05 | 222 | 80 | 7 | 1.25.10.10 | |
| Domain | Cadherin_CS | 1.05e-04 | 109 | 80 | 5 | IPR020894 | |
| Domain | CADHERIN_1 | 1.24e-04 | 113 | 80 | 5 | PS00232 | |
| Domain | Cadherin | 1.24e-04 | 113 | 80 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 1.30e-04 | 114 | 80 | 5 | PS50268 | |
| Domain | - | 1.30e-04 | 114 | 80 | 5 | 2.60.40.60 | |
| Domain | CA | 1.35e-04 | 115 | 80 | 5 | SM00112 | |
| Domain | Cadherin-like | 1.41e-04 | 116 | 80 | 5 | IPR015919 | |
| Domain | Cadherin | 1.52e-04 | 118 | 80 | 5 | IPR002126 | |
| Domain | ARM-like | 1.58e-04 | 270 | 80 | 7 | IPR011989 | |
| Domain | Cadherin_pro | 3.75e-04 | 7 | 80 | 2 | PF08758 | |
| Domain | Cadherin_pro_dom | 4.99e-04 | 8 | 80 | 2 | IPR014868 | |
| Domain | Cadherin_pro | 4.99e-04 | 8 | 80 | 2 | SM01055 | |
| Domain | VDCCAlpha1 | 7.97e-04 | 10 | 80 | 2 | IPR002077 | |
| Domain | HEAT | 1.14e-03 | 48 | 80 | 3 | PF02985 | |
| Domain | OLF | 1.37e-03 | 13 | 80 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 1.37e-03 | 13 | 80 | 2 | IPR003112 | |
| Domain | OLF | 1.37e-03 | 13 | 80 | 2 | SM00284 | |
| Domain | OLF | 1.37e-03 | 13 | 80 | 2 | PF02191 | |
| Domain | - | 1.83e-03 | 15 | 80 | 2 | 1.10.150.60 | |
| Domain | Pept_M10A_Zn_BS | 1.83e-03 | 15 | 80 | 2 | IPR021158 | |
| Domain | BRIGHT | 1.83e-03 | 15 | 80 | 2 | SM00501 | |
| Domain | ARID_dom | 1.83e-03 | 15 | 80 | 2 | IPR001606 | |
| Domain | ARID | 1.83e-03 | 15 | 80 | 2 | PS51011 | |
| Domain | ARID | 1.83e-03 | 15 | 80 | 2 | PF01388 | |
| Domain | HEAT | 1.97e-03 | 58 | 80 | 3 | IPR000357 | |
| Domain | HEAT_type_2 | 2.36e-03 | 17 | 80 | 2 | IPR021133 | |
| Domain | Hemopexin_CS | 2.36e-03 | 17 | 80 | 2 | IPR018486 | |
| Domain | Pept_M10A_stromelysin-type | 2.65e-03 | 18 | 80 | 2 | IPR016293 | |
| Domain | PG_binding_1 | 3.27e-03 | 20 | 80 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 3.27e-03 | 20 | 80 | 2 | IPR002477 | |
| Domain | ARM-type_fold | 3.33e-03 | 339 | 80 | 6 | IPR016024 | |
| Domain | HEAT_REPEAT | 3.37e-03 | 70 | 80 | 3 | PS50077 | |
| Domain | Hemopexin-like_dom | 4.32e-03 | 23 | 80 | 2 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 4.32e-03 | 23 | 80 | 2 | IPR018487 | |
| Domain | M10A_MMP | 4.32e-03 | 23 | 80 | 2 | IPR033739 | |
| Domain | Hemopexin | 4.32e-03 | 23 | 80 | 2 | PF00045 | |
| Domain | HEMOPEXIN | 4.32e-03 | 23 | 80 | 2 | PS00024 | |
| Domain | - | 4.32e-03 | 23 | 80 | 2 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 4.32e-03 | 23 | 80 | 2 | PS51642 | |
| Domain | HX | 4.32e-03 | 23 | 80 | 2 | SM00120 | |
| Domain | Pept_M10A | 4.32e-03 | 23 | 80 | 2 | IPR021190 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 6.08e-07 | 67 | 65 | 6 | MM15327 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 1.04e-06 | 40 | 65 | 5 | MM15060 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 2.62e-06 | 48 | 65 | 5 | MM15069 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 2.86e-06 | 87 | 65 | 6 | M27617 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 5.74e-06 | 98 | 65 | 6 | M39830 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 6.76e-06 | 58 | 65 | 5 | M11980 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.34e-05 | 32 | 65 | 4 | MM15326 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.93e-05 | 121 | 65 | 6 | M39823 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 2.10e-05 | 73 | 65 | 5 | MM15126 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 5.79e-05 | 90 | 65 | 5 | M820 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 7.27e-05 | 18 | 65 | 3 | M48098 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 7.89e-05 | 96 | 65 | 5 | MM14592 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.26e-04 | 56 | 65 | 4 | M27616 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 2.01e-04 | 117 | 65 | 5 | M19248 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 7.32e-04 | 155 | 65 | 5 | M522 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 8.58e-04 | 335 | 65 | 7 | MM14503 | |
| Pubmed | 1.90e-10 | 15 | 82 | 5 | 33833667 | ||
| Pubmed | E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. | 9.71e-10 | 20 | 82 | 5 | 7806582 | |
| Pubmed | Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. | 5.96e-09 | 10 | 82 | 4 | 2059658 | |
| Pubmed | Motor neuron position and topographic order imposed by β- and γ-catenin activities. | 7.31e-09 | 29 | 82 | 5 | 22036570 | |
| Pubmed | 1.26e-08 | 3 | 82 | 3 | 32011705 | ||
| Pubmed | 1.26e-08 | 3 | 82 | 3 | 18628683 | ||
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 5.04e-08 | 4 | 82 | 3 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 5.04e-08 | 4 | 82 | 3 | 22671294 | |
| Pubmed | 5.04e-08 | 4 | 82 | 3 | 20579107 | ||
| Pubmed | 5.04e-08 | 4 | 82 | 3 | 16077734 | ||
| Pubmed | 5.04e-08 | 4 | 82 | 3 | 17292328 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 8.10e-08 | 91 | 82 | 6 | 28558017 | |
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 1.26e-07 | 5 | 82 | 3 | 10996085 | |
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 37865312 | ||
| Pubmed | 2.51e-07 | 6 | 82 | 3 | 21838267 | ||
| Pubmed | 2.51e-07 | 6 | 82 | 3 | 29724786 | ||
| Pubmed | Type II cadherins guide assembly of a direction-selective retinal circuit. | 2.94e-07 | 24 | 82 | 4 | 25126785 | |
| Pubmed | IL1RAPL1 ARID1B WDR64 CEP295 CHD2 COLGALT2 ARID1A HSPA12B BABAM2 ZNF687 DNAH11 | 3.13e-07 | 638 | 82 | 11 | 31182584 | |
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 4.12e-07 | 26 | 82 | 4 | 34848499 | |
| Pubmed | 4.39e-07 | 7 | 82 | 3 | 8879495 | ||
| Pubmed | Genetic dissection of cadherin function during nephrogenesis. | 4.39e-07 | 7 | 82 | 3 | 11839813 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 7.01e-07 | 8 | 82 | 3 | 30871858 | |
| Pubmed | 1.05e-06 | 9 | 82 | 3 | 23010509 | ||
| Pubmed | 1.50e-06 | 10 | 82 | 3 | 10861224 | ||
| Pubmed | 1.50e-06 | 10 | 82 | 3 | 27151949 | ||
| Pubmed | 2.03e-06 | 157 | 82 | 6 | 30186101 | ||
| Pubmed | 2.06e-06 | 11 | 82 | 3 | 32973045 | ||
| Pubmed | 2.06e-06 | 11 | 82 | 3 | 26403076 | ||
| Pubmed | 2.69e-06 | 497 | 82 | 9 | 23414517 | ||
| Pubmed | 2.74e-06 | 12 | 82 | 3 | 22102170 | ||
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 3.55e-06 | 13 | 82 | 3 | 27050589 | |
| Pubmed | 3.55e-06 | 13 | 82 | 3 | 9615235 | ||
| Pubmed | 4.34e-06 | 46 | 82 | 4 | 20301533 | ||
| Pubmed | Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse. | 4.51e-06 | 14 | 82 | 3 | 20847152 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 8247017 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 34386776 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 27782075 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 23202128 | ||
| Pubmed | Not all neuroligin 3 and 4X missense variants lead to significant functional inactivation. | 5.49e-06 | 2 | 82 | 2 | 28948087 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 33890484 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 11171339 | ||
| Pubmed | Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. | 5.49e-06 | 2 | 82 | 2 | 16648374 | |
| Pubmed | A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population. | 5.49e-06 | 2 | 82 | 2 | 19645625 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 18434543 | ||
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 5.49e-06 | 2 | 82 | 2 | 24562383 | |
| Pubmed | Mutation screening of X-chromosomal neuroligin genes: no mutations in 196 autism probands. | 5.49e-06 | 2 | 82 | 2 | 15274046 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 15836428 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 23183221 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24855039 | ||
| Pubmed | Analysis of the genes encoding neuroligins NLGN3 and NLGN4 in Bulgarian patients with autism. | 5.49e-06 | 2 | 82 | 2 | 23431752 | |
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 5.49e-06 | 2 | 82 | 2 | 37001827 | |
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 5.49e-06 | 2 | 82 | 2 | 37080762 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 16508939 | ||
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 5.49e-06 | 2 | 82 | 2 | 37611161 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 32791957 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 5.49e-06 | 2 | 82 | 2 | 29890703 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 29106499 | ||
| Pubmed | NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. | 5.49e-06 | 2 | 82 | 2 | 15389766 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 5.49e-06 | 2 | 82 | 2 | 24104404 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 38003293 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 10662782 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24788099 | ||
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 5.49e-06 | 2 | 82 | 2 | 32243781 | |
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 5.49e-06 | 2 | 82 | 2 | 28967863 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 33052929 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 22989184 | ||
| Pubmed | Variations analysis of NLGN3 and NLGN4X gene in Chinese autism patients. | 5.49e-06 | 2 | 82 | 2 | 24570023 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 18189281 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 26685716 | ||
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 5.49e-06 | 2 | 82 | 2 | 27562491 | |
| Pubmed | Disorder-associated mutations lead to functional inactivation of neuroligins. | 5.49e-06 | 2 | 82 | 2 | 15150161 | |
| Pubmed | Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. | 5.49e-06 | 2 | 82 | 2 | 15622415 | |
| Pubmed | PHD Finger Protein 19 Promotes Cardiac Hypertrophy via Epigenetically Regulating SIRT2. | 5.49e-06 | 2 | 82 | 2 | 33611744 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 23851596 | ||
| Pubmed | 5.63e-06 | 15 | 82 | 3 | 18227507 | ||
| Pubmed | Cadherin expression in the developing mouse olfactory system. | 6.92e-06 | 16 | 82 | 3 | 17278136 | |
| Pubmed | CACNA1A NLGN3 DNAJC13 UACA MAGED2 SYNE1 YLPM1 GRIA4 CDH2 TENM2 KPNB1 | 1.62e-05 | 963 | 82 | 11 | 28671696 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 33432679 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 21647563 | ||
| Pubmed | Cadherins Interact With Synaptic Organizers to Promote Synaptic Differentiation. | 1.64e-05 | 3 | 82 | 2 | 29760652 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 34044070 | ||
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 1.64e-05 | 3 | 82 | 2 | 26716708 | |
| Pubmed | Significance of neurexin and neuroligin polymorphisms in regulating risk of Hirschsprung's disease. | 1.64e-05 | 3 | 82 | 2 | 29622757 | |
| Pubmed | Regulation of CHD2 expression by the Chaserr long noncoding RNA gene is essential for viability. | 1.64e-05 | 3 | 82 | 2 | 31704914 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 26156959 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 1.64e-05 | 3 | 82 | 2 | 22426308 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 24382590 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 1406710 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 1.64e-05 | 3 | 82 | 2 | 21282647 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 34512623 | ||
| Pubmed | 1.94e-05 | 233 | 82 | 6 | 37704626 | ||
| Pubmed | PIK3R4 CACNA1A NDUFB11 NLGN3 SIRT2 DNAJC13 SYNE1 ARID1A NT5DC3 CDH2 MRPS22 KPNB1 DNAH11 | 2.91e-05 | 1431 | 82 | 13 | 37142655 | |
| Pubmed | Functional roles of MMP14 and MMP15 in early postnatal mammary gland development. | 3.28e-05 | 4 | 82 | 2 | 27633994 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 14673996 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 38254206 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 28957665 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 16461340 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 23468870 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 16705170 | ||
| Interaction | CDH7 interactions | 3.45e-06 | 8 | 81 | 3 | int:CDH7 | |
| Interaction | CDH6 interactions | 3.45e-06 | 8 | 81 | 3 | int:CDH6 | |
| Interaction | CDH9 interactions | 1.34e-05 | 12 | 81 | 3 | int:CDH9 | |
| GeneFamily | CD molecules|Type II classical cadherins | 9.22e-06 | 13 | 59 | 3 | 1186 | |
| GeneFamily | CD molecules|Type I classical cadherins | 1.04e-04 | 5 | 59 | 2 | 1185 | |
| GeneFamily | AT-rich interaction domain containing | 1.07e-03 | 15 | 59 | 2 | 418 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 2.76e-03 | 24 | 59 | 2 | 891 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.24e-03 | 26 | 59 | 2 | 253 | |
| ToppCell | 18-Distal-Epithelial-Basal_cell|Distal / Age, Tissue, Lineage and Cell class | 4.79e-07 | 158 | 82 | 6 | 183f445967e09e871c93d8e94781ed9fec894169 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.18e-07 | 165 | 82 | 6 | 369d77a80d6401e85ea3121ab5a252f67d5f157e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.86e-07 | 168 | 82 | 6 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.35e-07 | 170 | 82 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-07 | 171 | 82 | 6 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.31e-07 | 177 | 82 | 6 | 0417460bdb012bc43d7254377fa53d79cdab3f34 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-06 | 181 | 82 | 6 | 098dbb3e0ff531c9720a233123250c1e39a97d4c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 185 | 82 | 6 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-06 | 186 | 82 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.63e-06 | 195 | 82 | 6 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-06 | 198 | 82 | 6 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-06 | 199 | 82 | 6 | 9e32644b93fb1c4946dbe388fd5c357304d14e36 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.89e-06 | 200 | 82 | 6 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.89e-06 | 200 | 82 | 6 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.89e-06 | 200 | 82 | 6 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.90e-06 | 139 | 82 | 5 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.01e-06 | 148 | 82 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 159 | 82 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.70e-05 | 173 | 82 | 5 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.80e-05 | 175 | 82 | 5 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.80e-05 | 175 | 82 | 5 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.80e-05 | 175 | 82 | 5 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 177 | 82 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 177 | 82 | 5 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 177 | 82 | 5 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.90e-05 | 177 | 82 | 5 | 59726bfd98f656fdcedf448a7e2e76a9bfad8285 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-05 | 178 | 82 | 5 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 179 | 82 | 5 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 179 | 82 | 5 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 2.06e-05 | 180 | 82 | 5 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-05 | 180 | 82 | 5 | 0059e5acade6c895fd629767bea1c15f40b0d1b0 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.06e-05 | 180 | 82 | 5 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-05 | 180 | 82 | 5 | dfb8412e1e06fa7349e66eea2ef27d9ea98b7893 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-05 | 181 | 82 | 5 | a436e7e4c36403257ea90160a58ca0d6d7c0cdfc | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.17e-05 | 182 | 82 | 5 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-05 | 182 | 82 | 5 | d1c3cc2942faec7527a3c25869fd65c17899e5e4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-05 | 182 | 82 | 5 | 92f83f29e358000cd86a709eb8b6199761ffe8bd | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 182 | 82 | 5 | f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-05 | 182 | 82 | 5 | 02baca9a72c7b559c3e452693b3b134af804c868 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.23e-05 | 183 | 82 | 5 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-05 | 184 | 82 | 5 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-05 | 184 | 82 | 5 | 226ccac00ac1c3a0ad7283785fd14312320e0ca6 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.35e-05 | 185 | 82 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | wk_08-11-Epithelial-PNS-COL20A1+_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.35e-05 | 185 | 82 | 5 | abec2a49fe0f0fa4cba49347207a1ee317333657 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.41e-05 | 186 | 82 | 5 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-05 | 186 | 82 | 5 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.54e-05 | 188 | 82 | 5 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-05 | 188 | 82 | 5 | ccd2541892112a7a303f766adf9a7afeb754498c | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 2.60e-05 | 189 | 82 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-05 | 189 | 82 | 5 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 2.60e-05 | 189 | 82 | 5 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.60e-05 | 189 | 82 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.67e-05 | 190 | 82 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.67e-05 | 190 | 82 | 5 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-05 | 190 | 82 | 5 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.67e-05 | 190 | 82 | 5 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-05 | 191 | 82 | 5 | 239c1e68eb1cbe3e137a99fbd6eeb8d64c919ffd | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.74e-05 | 191 | 82 | 5 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.74e-05 | 191 | 82 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.81e-05 | 192 | 82 | 5 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.88e-05 | 193 | 82 | 5 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-05 | 193 | 82 | 5 | d5930f7bd9b299f792212d40a3272a37adf64a82 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-05 | 193 | 82 | 5 | a9349ed5f3c34dcf817b3e84737e5946922ddff3 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-05 | 193 | 82 | 5 | cdc44bf6f5436eb8a2d4720fe011dcb85ccecf87 | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.88e-05 | 193 | 82 | 5 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.95e-05 | 194 | 82 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-immature_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.95e-05 | 194 | 82 | 5 | bf8e78d53802ac758be1c3db833779c26a94e1d5 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.95e-05 | 194 | 82 | 5 | 3b9ada901dfe7a5cc4861a883d3268c53b11e5b6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 196 | 82 | 5 | 34e79918a448f6c19b87e1b1ce13c012b24be1f8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.10e-05 | 196 | 82 | 5 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.10e-05 | 196 | 82 | 5 | 624f700daea48d9bad4cc554f4776bd809ae1e54 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.10e-05 | 196 | 82 | 5 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 196 | 82 | 5 | 8f82e01ca50aa4cd6149547505b4474a02fad618 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.10e-05 | 196 | 82 | 5 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | NS-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.18e-05 | 197 | 82 | 5 | 5fb0696376a5501b7c87e0f2f5e4fff3da2903f2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 82 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-05 | 198 | 82 | 5 | 36c97eb71b89bac01cabd6a8b728e5a20e52d2a3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-05 | 198 | 82 | 5 | 50dfe6efca76ea9683a19b6bff59cb5030d346f1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-05 | 198 | 82 | 5 | c8272ac4d90f2367f538f66db40de911ad73ea7f | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-05 | 198 | 82 | 5 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-05 | 198 | 82 | 5 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 199 | 82 | 5 | ce699726ac4825c65bf934cb9a76202ad7340596 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 3.33e-05 | 199 | 82 | 5 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 199 | 82 | 5 | f1d5808ccb1d5d4e2d34f864e705e2484000e88f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 199 | 82 | 5 | f1723cfd6fbb8c8903a3b167872ec8523e3be250 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_Myelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-05 | 199 | 82 | 5 | 2b567b6fd8addf059bbf2b72c55a7647aefdc595 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.41e-05 | 200 | 82 | 5 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.41e-05 | 200 | 82 | 5 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.41e-05 | 200 | 82 | 5 | 30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-05 | 200 | 82 | 5 | 4f481d87e30195365900acb5d50641a9e7b2f462 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.41e-05 | 200 | 82 | 5 | 5490393c5f54748f912676e19b58bd1320415a06 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-05 | 200 | 82 | 5 | de55100e98d3e9b8a74e37aebcd3afa2b0996527 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 3.41e-05 | 200 | 82 | 5 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 3.41e-05 | 200 | 82 | 5 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-05 | 200 | 82 | 5 | cf720d3973e79ffd4c6e763a7284799ced22a274 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-05 | 200 | 82 | 5 | df821ac12953e44fcfedbbefb35a4976e406ccd6 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.41e-05 | 200 | 82 | 5 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 7.64e-05 | 122 | 82 | 4 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.66e-05 | 126 | 82 | 4 | 28fbe63f7bc628b32d8e86bf9e80657e776dd1cc | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.30e-04 | 140 | 82 | 4 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| Drug | (+,-)-Synephrine [94-07-5]; Down 200; 24uM; HL60; HT_HG-U133A | 5.50e-06 | 194 | 80 | 7 | 6156_DN | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; PC3; HT_HG-U133A | 5.88e-06 | 196 | 80 | 7 | 3776_DN | |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; PC3; HT_HG-U133A | 5.88e-06 | 196 | 80 | 7 | 6633_UP | |
| Drug | enzacamene | 6.28e-06 | 129 | 80 | 6 | ctd:C038939 | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | 6.28e-06 | 198 | 80 | 7 | 5815_UP | |
| Drug | Raloxifene Hydrochloride | OLFML2A TNFRSF25 CLK1 NFIL3 CYP27A1 CACNA1I FGFR2 MMP3 CDH2 NOS2 CDH6 INPP4B KPNB1 | 8.50e-06 | 857 | 80 | 13 | ctd:D020849 |
| Drug | octylmethoxycinnamate | 9.63e-06 | 139 | 80 | 6 | ctd:C118580 | |
| Drug | palladium oxide | 1.22e-05 | 2 | 80 | 2 | CID000073974 | |
| Drug | butylparaben | 1.93e-05 | 157 | 80 | 6 | ctd:C038091 | |
| Drug | 2-amino-6-chloropurine | 3.28e-05 | 18 | 80 | 3 | CID005360349 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 6.13e-05 | 193 | 80 | 6 | 3262_UP | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 6059_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 5287_UP | |
| Drug | CP-863187 [668981-07-5]; Up 200; 10uM; PC3; HT_HG-U133A | 6.67e-05 | 196 | 80 | 6 | 7512_UP | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A | 6.67e-05 | 196 | 80 | 6 | 7391_DN | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; HL60; HT_HG-U133A | 6.67e-05 | 196 | 80 | 6 | 2742_UP | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 4751_DN | |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; HL60; HG-U133A | 6.86e-05 | 197 | 80 | 6 | 2038_UP | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 3364_UP | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; HL60; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 2492_UP | |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; HL60; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 2995_DN | |
| Drug | Tropine [120-29-6]; Down 200; 28.4uM; PC3; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 5790_DN | |
| Drug | Troleandomycin [2751-09-9]; Up 200; 5uM; MCF7; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 1465_UP | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; HL60; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 2470_UP | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 6033_DN | |
| Drug | Linuron | 8.91e-05 | 128 | 80 | 5 | ctd:D008044 | |
| Disease | Malignant neoplasm of breast | AKAP6 PIK3R4 ARID1B TBC1D9B MAGED2 SYNE1 COLGALT2 FGFR2 MMP3 ARID1A CDH2 NOS2 MRPS22 INPP4B NLRP8 | 2.03e-07 | 1074 | 81 | 15 | C0006142 |
| Disease | Autism Spectrum Disorders | 3.80e-06 | 85 | 81 | 5 | C1510586 | |
| Disease | Breast Carcinoma | 1.70e-05 | 538 | 81 | 9 | C0678222 | |
| Disease | Antenatal Bartter syndrome | 2.23e-05 | 3 | 81 | 2 | cv:CN239220 | |
| Disease | Bartter syndrome, antenatal type 1 | 2.23e-05 | 3 | 81 | 2 | C1866495 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.87e-05 | 24 | 81 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.87e-05 | 24 | 81 | 3 | C3805278 | |
| Disease | Cholangiocarcinoma | 4.95e-05 | 26 | 81 | 3 | C0206698 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.35e-05 | 152 | 81 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 7.40e-05 | 5 | 81 | 2 | C3281201 | |
| Disease | Bartter syndrome | 1.11e-04 | 6 | 81 | 2 | cv:C0004775 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.97e-04 | 41 | 81 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.97e-04 | 41 | 81 | 3 | C0858252 | |
| Disease | neuroblastoma (is_implicated_in) | 3.30e-04 | 10 | 81 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Liver carcinoma | 4.93e-04 | 507 | 81 | 7 | C2239176 | |
| Disease | cognitive function measurement | AKAP6 IL1RAPL1 ARID1B HEATR4 GRIA4 CACNA1I CHD2 CDH2 CDH4 IQCM CDH7 CDH9 | 5.24e-04 | 1434 | 81 | 12 | EFO_0008354 |
| Disease | Coffin-Siris syndrome | 5.69e-04 | 13 | 81 | 2 | C0265338 | |
| Disease | abdominal aortic aneurysm (biomarker_via_orthology) | 6.63e-04 | 14 | 81 | 2 | DOID:7693 (biomarker_via_orthology) | |
| Disease | Autistic Disorder | 7.72e-04 | 261 | 81 | 5 | C0004352 | |
| Disease | response to methotrexate | 8.71e-04 | 16 | 81 | 2 | GO_0031427 | |
| Disease | matrix metalloproteinase 12 measurement | 1.11e-03 | 18 | 81 | 2 | EFO_0010590 | |
| Disease | behavioural disinhibition measurement | 1.17e-03 | 75 | 81 | 3 | EFO_0006946 | |
| Disease | citrate measurement | 1.36e-03 | 79 | 81 | 3 | EFO_0010114 | |
| Disease | X-24309 measurement | 1.37e-03 | 20 | 81 | 2 | EFO_0800872 | |
| Disease | Nasopharyngeal carcinoma | 1.66e-03 | 22 | 81 | 2 | C2931822 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 1.81e-03 | 23 | 81 | 2 | DOID:0050156 (is_marker_for) | |
| Disease | Coronary heart disease | 1.98e-03 | 24 | 81 | 2 | C0010068 | |
| Disease | ankylosing spondylitis | 2.03e-03 | 91 | 81 | 3 | EFO_0003898 | |
| Disease | refractive error | 2.06e-03 | 326 | 81 | 5 | MONDO_0004892 | |
| Disease | Abnormality of refraction | 2.52e-03 | 673 | 81 | 7 | HP_0000539 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 2.59e-03 | 99 | 81 | 3 | EFO_0004611, EFO_0007878 | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 2.69e-03 | 28 | 81 | 2 | DOID:12236 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KMKKDIYWDDSAARP | 331 | Q8N1M1 | |
| DLYDDWMRAASLKEP | 371 | Q6ZT62 | |
| QFLDKMDDPDYWRTV | 171 | Q14137 | |
| EMDPDERWKAAYTRH | 796 | O00555 | |
| RWGERKSKPNMNYDK | 86 | Q99581 | |
| DFRVFDSWFKVDMKP | 1101 | Q96DT5 | |
| EPERKLWVDRYLTFM | 1136 | Q8NFD5 | |
| KIEDFREEMWTFRGK | 61 | Q6NSX1 | |
| PAKYAETMDREFRKW | 191 | Q8TEK3 | |
| FSYDDKWVSVMERPK | 466 | Q7L5Y6 | |
| MRHSKRTYCPDWDDK | 1 | P49759 | |
| MPEEKKDTVYWEKRR | 36 | A0A5F9ZHS7 | |
| YEIMFAKREDWPKIE | 366 | A0A1B0GVH7 | |
| GEPERKMWVDRYLAF | 1016 | O14497 | |
| KMWVDRYLAFTEEKA | 1021 | O14497 | |
| IYMPKEKRARFSELW | 161 | Q7Z5J8 | |
| VLEVAMEHPKYEWFR | 326 | P35228 | |
| MEHPKYEWFRELELK | 331 | P35228 | |
| KRAPYWTNTEKMEKR | 151 | P21802 | |
| MAPKAWKVLTDYYRS | 596 | O95340 | |
| KDPKEWAAQYREAME | 466 | Q9UNF1 | |
| VEFILMFYRDKPIDW | 316 | Q9UQ53 | |
| RRYKSNVMEKFFPIW | 151 | Q86W28 | |
| CKLYRFPTSDNKWMR | 236 | O15327 | |
| GTKYWKFDNERLRME | 531 | P51511 | |
| DKYWRFDEKRNSMEP | 406 | P08254 | |
| MDRWKKLDQREYPGS | 276 | P48058 | |
| FWKRLQYEMPFKRIE | 551 | Q9NZN1 | |
| ARWMEKHGFERPKYF | 471 | Q8NCN5 | |
| FIPDEKKDAMYWEKR | 66 | Q16649 | |
| VDTVFRFDPRYNKWM | 366 | Q9P2J3 | |
| PEEARDWLYFEKFKM | 131 | Q96MM6 | |
| WRLVDSKGFDEYMKE | 11 | Q01469 | |
| RETIKFMYTDWADRD | 451 | Q9NZ94 | |
| LRETIKFMYTDWADK | 416 | Q8NFZ3 | |
| RLDMPEVLWKSYIDF | 671 | Q9BZJ0 | |
| EMELAIFEKWKEYRG | 196 | Q9HCM4 | |
| PRWDGNEMAKRAKAY | 351 | Q9NXR7 | |
| FKEERPEEYESWREM | 641 | Q14241 | |
| ELSKDMRPFFEEYWA | 21 | Q9HB03 | |
| ERIADVKKMWEEYPD | 91 | O14647 | |
| RKMIDVYKPDWCEVR | 1131 | Q9P0X4 | |
| EGKYPVRNDMELWKE | 121 | Q02318 | |
| MQRDPYWKIKAFAIR | 771 | Q86WZ0 | |
| LNDWGPRFKKLADMY | 896 | P55283 | |
| PDMKRESEKEWYFGN | 966 | O75165 | |
| KNPDWRYRDAAVMAF | 376 | Q14974 | |
| YLSDWGPRFKKLADM | 766 | P55285 | |
| YLSDWGPRFKRLADM | 761 | Q9ULB5 | |
| ERLDYPKSRMAIWAA | 76 | Q8IYK4 | |
| LVELPYKRSEMKEDW | 286 | Q9C0D2 | |
| YLSDWGPRFKKLADM | 766 | Q9ULB4 | |
| LRETIKFMYTDWADK | 416 | Q8N0W4 | |
| YLNDWGPRFKKLADM | 886 | P19022 | |
| VAYLPDYRMKEWSRR | 106 | Q9NX14 | |
| GAWMKDPAARDDRIY | 416 | Q68BL7 | |
| WEERDRMIQVYFPKE | 186 | P82650 | |
| YDSMPRRKEAWFSPV | 356 | Q13884 | |
| YRKLMEDPDKWKDYT | 1116 | Q8NF91 | |
| WALFYPKRAMDQARE | 606 | Q8TC59 | |
| PDMKRYLWERYREAK | 51 | Q86UY8 | |
| GAVDEPYDRRFVKWM | 356 | Q16773 | |
| RHEYPLSWMKEKIFS | 201 | Q8IXJ6 | |
| GMDFDSKKAYRDVAW | 306 | Q8IXJ6 | |
| ESWKVFEEMIEPYRL | 986 | Q13621 | |
| YDFMERLDGKEKWSV | 506 | Q9NT68 | |
| AWMKDPLAKDERIYV | 516 | Q68BL8 | |
| PDYRHYLRMWAKEKE | 996 | Q66K14 | |
| WSYSEMEKEFPELIR | 256 | Q13023 | |
| WFMRADDDVYIKGDK | 256 | Q70JA7 | |
| SDMKIRFWDLAYPER | 1261 | Q99570 | |
| YEWVHKPREMDTSRR | 331 | Q9H9Y2 | |
| EEKFEASRGWFMRFK | 126 | Q96MW7 | |
| FYWKKMPSRTFIARE | 191 | Q96MW7 | |
| EKMAEPEKLTARVYW | 191 | O60687 | |
| RRYADYRHPDMWKND | 256 | Q7Z699 | |
| AYMPLRAKRWAAELD | 481 | Q5T6S3 | |
| KERLKWKSDYPMTDG | 31 | Q9HAC8 | |
| YDVMDAVPARRWKEF | 336 | Q93038 | |
| DTWREKRDYVPDRMD | 1381 | P49750 | |
| YFTREEWGMLDKRQK | 341 | O60290 | |
| WNKYDDRLMKAAERG | 31 | Q9BZF9 | |
| WFPERDEYVAHMKKE | 971 | Q8N1G0 | |
| DDKMVRFWRIDEDYP | 331 | Q9Y6I7 | |
| PDDEKGRQMWRKYLE | 391 | O75604 | |
| SKMWRDDREQFYKIA | 141 | P60604 | |
| YPLIFDREKWRKMSS | 946 | B1ANS9 |